Overall N = 127 | Everyday driver N = 77 | Occasional driver N = 50 | OR (95% CI) | p value | |
---|---|---|---|---|---|
(1) Polypharmacy | |||||
Number of drugs prescribed more than 2 weeks, median [IQR] | 4 [2, 6] | 4 [2, 6] | 3.5 [2, 5] | - | 0.36 |
Polypharmacya | 35 (27.6) | 24 (31.2) | 11 (22.0) | 0.63 (0.25–1.52) | 0.35 |
-Including BZ drugs | 16 (12.5) | 11 (14.3) | 5 (10.0) | 0.67 (0.17–2.26) | 0.59 |
-Including anti-histamine drugs | 4 (3.1) | 2 (2.6) | 2 (4.0) | 1.56 (0.11–22.2) | 0.65 |
(2) Sarcopeniab | |||||
No | 114 (89.8) | 66 (85.7) | 48 (96.0) | Reference | |
Yes | 11 (8.7) | 10 (13.0) | 1 (2.0) | 0.14 (0.003–1.04) | 0.049 |
No data | 2 (1.6) | 1 (1.3) | 1 (2.0) | - | |
- Finger-ring test | |||||
No risk of Sarcopenia | 41 (32.3) | 26 (33.8) | 15 (30.0) | Reference | |
Increased Risk of Sarcopenia | 64 (50.4) | 36 (46.8) | 28 (56.0) | - | |
Risk of Sarcopenia | 22 (17.3) | 15 (19.5) | 7 (14.0) | 0.81 (0.23–2.73) | 0.79 |
- 30-s chair-stand test | |||||
No risk of Sarcopenia | 61 (48) | 33 (42.9) | 28 (56.0) | Reference | |
Risk of Sarcopenia | 64 (50.4) | 43 (55.8) | 21 (42.0) | 0.58 (0.26–1.26) | 0.15 |
No data | 2 (1.6) | 1 (1.3) | 1 (2.0) | - | |
(3) Dementia | |||||
- Mini-cog | |||||
Not indicative of dementia (Score at 4 or 5) | 106 (82.8) | 63 (81.2%) | 43 (86.0%) | Reference | |
Risk of Dementia (Score at 0–3) | 21 (16.4) | 14 (18.2%) | 7 (14.0%) | 0.73 (0.23–2.14) | 0.63 |
(4) Frail | |||||
- Frail Index | |||||
Not Frail (Score at 0) | 28 (22.0) | 18 (23.4) | 10 (20.0) | Reference | |
Pre-Frail (Score at 1–2) | 80 (63.0) | 47 (61.0) | 33 (66.0) | - | |
Frail (Score at ≥ 3) | 19 (15.0) | 12 (15.6) | 7 (14.0) | 1.05 (0.26–4.1) | 1 |
- Oral Frail | |||||
Low risk (Score at 0–2) | 23 (18.1) | 14 (18.2) | 9 (18.0) | Reference | |
Intermediate risk (Score at 3) | 35 (27.6) | 24 (31.2) | 11 (22.0) | - | |
High risk (Score at ≥ 4) | 69 (54.3) | 39 (50.6) | 30 (60.0) | 1.2 (0.41–3.58) | 0.81 |